How digital pathology is advancing cancer diagnostics and paving the way for personalized medicine

14 Apr 2025

Discover how digital pathology is reshaping clinical labs and advancing precision medicine.

In this exclusive interview, Karan Arora, SVP of CDx and Pharma Partnerships at Leica Biosystems, explores the transformative power of digital pathology in cancer diagnostics. With firsthand insights from leading labs and global research teams, this PDF is a must-read for clinical laboratory scientists navigating the shift from traditional glass slides to a digital future.

Key takeaways:

  • The real-world drivers behind digital pathology adoption
  • How labs are using AI-powered insights to improve diagnostic accuracy and patient care
  • Key implementation steps for a smooth, scalable digital transition
  • Why digital platforms are revolutionizing education, collaboration, and operational efficiency
  • The growing impact of digital pathology on precision medicine and biopharma research

Switching to digital pathology isn’t just a nice-to-have anymore, but a must.

Karan Arora  SVP, Leica Biosystems

Links

Tags